Elena Masselli: Can Statins Enhance Peginterferon Therapy in MPNs?
Elena Masselli, Full Professor of Human Anatomy at the University of Parma and Consultant Hematologist at the University Hospital of Parma, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Blood Advances, adding:
“Thrilled to share our commentary recently published in Blood Advances on the paper by Professor Hans Hasselbalch’s group exploring the clinically relevant synergy between peginterferon and statins in patients with myeloproliferative neoplasms.
Our article discusses the signalling pathways that may contribute to the synergistic effects of these treatments.
We are truly honoured to have received such positive feedback from the authors!
Take a look and let us know your thoughts!”
Title: Are statins interferon’s best friend? Mechanistic insights
Authors: Giacomo Maria Cerreto, Cecilia Carubbi, Marco Vitale, Elena Masselli
Stay updated with Hemostasis Today.
-
Oct 28, 2026, 03:32Wolfgang Miesbach: Should Prophylaxis in Type 3 VWD Follow the Bleeding Phenotype?
-
Oct 28, 2026, 03:25Owen McCarty: Exploring Platelet Polyphosphates in Coagulation Under Flow
-
Oct 28, 2026, 03:19Arwa Z. Al-Riyami: Key Takeaways from the Blood Conference in Auckland
-
Oct 28, 2026, 03:14Kristopher Jonas: The Ethical Case for Compensated Plasma Donation
-
Oct 28, 2026, 03:09Amber Paratore Sanchez: Therapeutic Plasma Exchange in PTE Patients with Cold Agglutinins
-
Oct 28, 2026, 03:04Fonkou Steve: Overcoming Fear to Build a Lifelong Blood Donor
-
Oct 28, 2026, 03:00Joanne Marlor: NHS Blood and Transplant Opens Country’s Largest Donor Centre in Reading
-
Oct 27, 2026, 23:04Stefano Navarro: Hypertension Reprogrammes Megakaryocytes and Increases Platelet Responsiveness to Thrombin
-
Oct 27, 2026, 23:03Enrique M. San Norberto García: What Is the Best Treatment for Femoropopliteal in-Stent Restenosis